The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic MedicationBy Fabiana da Silva Alves, MS, Martijn Figee, MD, Therese van Amelsvoort, MD, PhD, Dick Veltman, MD, PhD, and Lieuwe de Haan, MD, PhD
Fear, Anxiety, and the Neuroimaging of PTSDBy Eileen P. Ahearn, MD, PhD, Timothy Juergens, MD, Tracey Smith, PhD, Dean Krahn, MD, MS, and Ned Kalin, MD
Contacts
Post a Comment
Reader Comments